A double blind randomised controlled trial to compare Flomaxtra 400mcgs and placebo in the prevention of acute urinary symptoms during 3D conformal radiotherapy for localised prostate cancer

Trial Profile

A double blind randomised controlled trial to compare Flomaxtra 400mcgs and placebo in the prevention of acute urinary symptoms during 3D conformal radiotherapy for localised prostate cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Tamsulosin (Primary)
  • Indications Prostate cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 29 Nov 2012 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
    • 06 Jan 2011 Status changed from suspended to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 04 May 2009 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top